$99.00
CJC-1295 with Ipamorelin is a popular combination often discussed in the world of peptide therapy research, particularly in fitness, anti-aging, and performance optimization communities. These compounds are classified as growth hormone secretagogues, meaning they are studied for their potential to stimulate the body’s natural release of growth hormone.
CJC-1295 is a synthetic peptide that is designed to increase growth hormone levels over an extended period by acting on the pituitary gland. Ipamorelin, on the other hand, is known for its selective action as a growth hormone releasing peptide (GHRP), often highlighted in research for its ability to promote pulsatile growth hormone release with minimal impact on cortisol or prolactin levels.
When combined, the CJC-1295 and Ipamorelin stack is frequently explored in research discussions for its possible synergistic effects, which may include:
It is important to understand that CJC-1295 and Ipamorelin are not approved medications for general medical use in many countries and are often categorized as research compounds. Their long-term safety, efficacy, and regulatory approval status remain subjects of ongoing scientific investigation.
Ketacyn Pharmaceuticals is a specialized pharmaceutical company dedicated to providing high-quality ketamine-based products for medical use in anesthesia, pain management, and emerging therapeutic applications. Our focus is on ensuring safe, reliable, and compliant delivery of these controlled substances to healthcare professionals and institutions worldwide.
